Showing results (1-10 of 743) with videos related to

Sort By:
Pageof 75
Seminars in Oncology|June 4, 2004
Increasing tumor uptake of anticancer drugs with imatinibKristian Pietras
Biochemical and Biophysical Research Communications|June 23, 2018
PDGF family function and prognostic value in tumor biologyMichael Bartoschek, Kristian Pietras
Upsala Journal of Medical Sciences|March 22, 2012
Of mice and men: a comparative study of cancer-associated fibroblasts in mammary carcinomaPernilla Roswall, Kristian Pietras
Cancer Science|June 24, 2020
Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicineRyu Kanzaki, Kristian Pietras
Experimental Cell Research|March 10, 2010
Hallmarks of cancer: interactions with the tumor stromaKristian Pietras, Arne Ostman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 2004
A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancerKristian Pietras, Douglas Hanahan
Upsala Journal of Medical Sciences|April 4, 2024
Cellular plasticity in the breast cancer ecosystemKristian Pietras, Jonas Sjölund
Blood|April 7, 2011
ALK1 as an emerging target for antiangiogenic therapy of cancerSara I Cunha, Kristian Pietras
The Journal of the Association of Physicians of India|January 31, 2014
Non-diabetic renal disease (NDRD) in patients with type 2 diabetes mellitus (type 2 DM)Jai Prakash
Trends in Cancer|July 26, 2017
Cancer-Associated Fibroblasts: Perspectives in Cancer TherapyJai Prakash
Pageof 75